Strides Shasun to hive-off its API business into wholly-owned subsidiary

18 Aug 2016 Evaluate

Strides Shasun has received an approval for hiving off its active pharmaceuticals ingredients (API) business into a wholly-owned subsidiary. The company’s board has given an in-principle approval to hive-off the API business into a wholly-owned subsidiary, subject to finalizing modalities of the transfer.

The API division had a turnover of Rs 712.2 crore in 2015-16. For the fiscal 2015-16, the company had consolidated net sales of Rs 3,014.33 crore with a net profit of Rs 208.92 crore.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.


Strides Pharma Scien Share Price

913.55 11.20 (1.24%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×